top of page

CheckEye Receives Western NIS Enterprise Fund Grant: A New Step in Chronic Disease Detection and Complication Prevention Using AI

CheckEye received a grant as part of the updated program from the Ukrainian Startup Fund, supported by the Western NIS Enterprise Fund (now Ukraine-Moldova American Enterprise Fund). This grant is a significant milestone in the development of the platform for mass screening of chronic diseases and will further expand its capabilities in preventive medicine.


CheckEye is an AI-based screening platform revolutionizing the detection of chronic diseases and preventing complications. The platform uses AI algorithms to conduct mass screenings for various health conditions—over 40 diseases in the roadmap, such as diabetic retinopathy (the leading cause of blindness in working-age individuals), hypertension (a top-three cause of premature death), eye diseases, Alzheimer's, Parkinson's, and more. By offering affordable and timely screening services, we aim to ensure access to healthcare and improve outcomes for everyone worldwide.


The grant application process began with the program's launch in February 2024 and concluded in April. The application included seven main categories: a detailed description of primary activities and market achievements, team presentation with descriptions of professional skills and experience, budget calculations for project implementation, identification of competitive advantages, market entry and expansion plans, and descriptions of ideas and social impact for society. The application was highly rated by the jury, who noted the team's professionalism, the project's innovation, and its importance to Ukraine and the global community. After a thorough review by the expert commission, we were invited to Pitch Day at the end of May, where we could personally present our project to the jury. As a result, we became one of the six teams to receive funding.


CheckEye has an international team bringing together experts from Ukraine, the United Kingdom, and Spain. Our core team has over 100 years of combined experience in IT, digital transformation, cybersecurity, medicine, healthcare, PR, and marketing. On Pitch Day, the company was represented by Kyrylo Honcharuk, founder and CEO of CheckEye. Kyrylo has over 20 years of experience in IT product development, digital transformation, and cybersecurity. He holds a Global Executive MBA from IESE Business School, University of Navarra, and is a board member of the Ukrainian Diabetes Federation. His achievements have been recognized with awards, including "CTO: Game changer of the year" in the EMEA region by Mobile Europe in 2023 and "Best CIO in the Ukrainian telecommunications industry" in 2019.


The Ukrainian Startup Fund, launched in 2019 and under the Ministry of Digital Transformation of Ukraine, along with the Western NIS Enterprise Fund, relaunched the support program for young Ukrainian tech companies in February this year. The program plans to allocate $2.5 million to support promising Ukrainian startups at the pre-seed and seed stages. Grants are provided for two years, with plans to fund 74 startups by the end of 2025. This program focuses on civilian startups, excluding military projects.


The received grant will be directed towards several key areas, including research, development, and certification. We plan to refine the front-end and patient accounting logic in accordance with GDPR requirements for data anonymization, improve the patient data logging system, create an API for integration with medical information systems, refine the classification neural network to reduce the likelihood of false positives, and optimize and accelerate the training of the classification model network. Additionally, we will implement a quality management system and prepare for an audit to meet international standards.


CheckEye's success has not gone unnoticed by the media. The company was featured in Forbes, which is a great honor and a testament to its contribution to the development of innovative technologies in Ukraine.

Komentarze


bottom of page